Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис:
http://hdl.handle.net/20.500.12188/9446| Наслов: | Final efficacy results of neratinib in HER2-positive hormone receptor-positive early-stage breast cancer from the phase III ExteNET trial | Authors: | Chan, Arlene Moy, Beverly Mansi, Janine Ejlertsen, Bent Holmes, Frankie Ann Chia, Stephen Iwata, Hiroji Gnant, Michael Loibl, Sibylle Barrios, Carlos H. Somali, Isil Smichkoska, Snezhana Martinez, Noelia Alonso, Mirta Garcia Link, John S. Mayer, Ingrid A. Cold, Søren Murillo, Serafin Morales Senecal, Francis Inoue, Kenichi Ruiz-Borrego, Manuel Hui, Rina Denduliri, Neelima Patt, Debra Rugo, Hope S. Johnston, Stephen R.D. Bryce, Richard Zhang, Bo Xu, Feng Wong, Alvin Martin, Miguel |
Issue Date: | окт-2020 | Publisher: | Elsevier BV | Journal: | Clinical Breast Cancer | URI: | http://hdl.handle.net/20.500.12188/9446 | DOI: | 10.1016/j.clbc.2020.09.014 |
| Appears in Collections: | Faculty of Medicine: Journal Articles |
Прикажи целосна запис
Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.